人类生殖技术市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按生殖技术(不孕症药物、避孕药)、性别和地理划分。

市场快照

Human Reproductive Technologies Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,全球人类生殖技术市场预计将以近 2% 的复合年增长率增长。不孕症患病率上升和计划生育延迟预计将引发市场增长。根据美国卫生与公众服务部的数据,每 100 对夫妇中就有一对在受孕方面面临问题,导致采用生殖技术来治疗不育率,这进一步引发了市场增长。此外,生活方式的改变,例如推迟生育第一个孩子、使用避孕药、增加饮酒和吸烟,导致不孕率上升,并为市场提供了显着推动力。预计提高患者对治疗与生殖相关问题的可用技术的认识将增加人类生殖技术的采用。然而,有限的保险范围可能会抑制市场的增长。

报告范围

根据报告的范围,人类生殖技术涉及生殖技术的所有当前和预期用途,包括不孕症治疗、避孕药和设备。这些技术涉及治疗不孕症和怀孕。

By Reproductive Technology
Infertility Treatment
Drugs
Follitropin Alfa
Follitropin Beta
Menotropins
Others
Devices
Sperm Separation Devices
Sperm Analyzer Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Others
Contraceptive
Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
Devices
Condoms
IUD
Cervical Caps
Diaphragms
Others
By Gender
Male
Female
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

避孕药具部分有望在人类生殖技术市场占据主要市场份额

由于口服药物是行业中最简单的避孕方式,因此避孕药预计将占据最大的市场份额,广泛的产品易于获得,对避孕药和装置的高度认识以及简单的给药方式是触发的关键因素细分市场增长。此外,性传播疾病 (STD) 发病率的上升、计划外怀孕率的上升以及政府举措的增加也是推动避孕药和器械市场发展的一些因素。

img 3 human reproductive technologies market

北美是最大的市场,亚太地区有望实现最快的增长。

北美处于所研究市场增长的最前沿,也是全球舞台上重要的收入贡献者。由于肥胖率高、受孕年龄的增加和生活方式的改变,不孕症率上升,这些都刺激了该地区的增长。根据美国卫生与公众服务部的数据,美国估计有 10% 的女性(610 万)无法怀孕。此外,预计轻松获得优质医疗保健和有利的报销政策将促进北美的收入增长。

亚太地区可能会在整个预测期内发布最快的市场。人口最多,对生殖技术的认识不断提高,西方生活方式的迅速采用导致了这些生殖技术的采用。此外,预计增加的医疗保健支出将推动亚太地区的市场。

Picture3.png

竞争格局

人类生殖技术市场在竞争方面是分散的,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司是 CooperSurgical, Inc.、Teva Pharmaceutical Industries、AbbVie Inc.、Ferring BV、Merck KGaA、Genea Limited 和 Ivftech。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Infertility

      2. 4.2.2 Delayed Family Planning

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Insurance Coverage

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Reproductive Technology

      1. 5.1.1 Infertility Treatment

        1. 5.1.1.1 Drugs

          1. 5.1.1.1.1 Follitropin Alfa

          2. 5.1.1.1.2 Follitropin Beta

          3. 5.1.1.1.3 Menotropins

          4. 5.1.1.1.4 Others

        2. 5.1.1.2 Devices

          1. 5.1.1.2.1 Sperm Separation Devices

          2. 5.1.1.2.2 Sperm Analyzer Systems

          3. 5.1.1.2.3 Ovum Aspiration Pumps

          4. 5.1.1.2.4 Micromanipulator Systems

          5. 5.1.1.2.5 Others

      2. 5.1.2 Contraceptive

        1. 5.1.2.1 Drugs

          1. 5.1.2.1.1 Oral Contraceptives

          2. 5.1.2.1.2 Topical Contraceptives

          3. 5.1.2.1.3 Contraceptive Injectable

        2. 5.1.2.2 Devices

          1. 5.1.2.2.1 Condoms

          2. 5.1.2.2.2 IUD

          3. 5.1.2.2.3 Cervical Caps

          4. 5.1.2.2.4 Diaphragms

          5. 5.1.2.2.5 Others

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 CooperSurgical, Inc.

      2. 6.1.2 Teva Pharmaceutical Industries

      3. 6.1.3 AbbVie Inc.

      4. 6.1.4 Ferring B.V.

      5. 6.1.5 Merck KGaA

      6. 6.1.6 Genea Limited

      7. 6.1.7 Ivftech

      8. 6.1.8 Bayer AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

CooperSurgical, Teva Pharmaceutical Industries, AbbVie Inc., Ferring B.V, Merck KGaA are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!